IL11 and chronic kidney disease: Mechanistic studies in mouse models and human cancer revealed that IL-11 production and phosphorylation of ERK are candidate targets of ω3FA, which could contribute to the reduction in inflammatory and CKD progression observed in clinical studies (Table 3).